The DOI matches its Crossref record.
Expression of standard CD44 in human colorectal carcinoma: Association with prognosis
Abstract
The aim of the present study was to evaluate the expression of standard CD44 (CD44s) in colorectal cancer (CRC), its relationship with clinicopathological characteristics, and its potential prognostic significance. CD44s levels were measured on immunohistochemistry in tumors and surrounding normal mucosa from 74 patients with primary colorectal carcinomas. The patients were followed for a median period of 37 months. Expression of CD44s in primary tumor and surrounding normal mucosa tissues was demonstrated in 100% (74/74) and 37.9% (28/74), respectively. The expression of CD44s in tumors was significantly associated with the depth of invasion (P = 0.034) and lymph node involvement (P = 0.031). A significant difference was observed between the overall survival and level of tumor CD44s expression, especially for stage IV carcinoma (P = 0.038). Multivariate analysis indicated that TNM stage (P = 0.020) and tumor CD44s expression (P = 0.008) were independent predictors of overall survival in adenocarcinomas. CD44s overexpression may be an independent unfavorable prognostic factor for overall survival in advanced CRC, especially stage IV disease. Further investigation, however, is necessary to assess the biological roles of CD44 in CRC, and validate their possible value as novel therapeutic targets.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nonetheless, CD44 expression varies widely between CRC stages [86,87]. This heterogeneity may limit uniform nanoparticle uptake across entire tumors.”
From Chitosan-Based Drug Delivery Systems for Targeted Chemotherapy in Colorectal Cancer: A Scoping Review (2025) · cites this paper as [86]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 21
- Furuta K, 1996, Relationship between cd44 expression and cell proliferation in epithelium and stroma of colorectal neoplasms, Am J Pathol, 149, 1147
- 10.1038/bjc.1993.354 · DOI
- 10.1081/CNV-200039658 · DOI
- 10.1080/00365529850170900 · DOI
- 10.1083/jcb.120.1.227 · DOI
- Ylagan LR, 2000, Cd44: A marker of squamous differentiation in adenosquamous neoplasms, Arch Pathol Lab Med, 124, 212, 10.5858/2000-124-0212-C · DOI
- 10.1177/29.4.6166661 · DOI
- Hart IR, 1989, Molecular aspects of the metastatic cascade, Biochim Biophys Acta, 989, 65
- Koopman G, 1990, Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA‐1 pathway, J Immunol, 145, 3589, 10.4049/jimmunol.145.11.3589 · DOI
- 10.1111/1523-1747.ep12874646 · DOI
- 10.1002/1097-0215(20010101)91:1<67::AID-IJC1011>3.0.CO;2-D · DOI
- 10.1111/j.1440-1827.2006.01946.x · DOI
- 10.1016/0959-8049(95)00252-E · DOI
- 10.1002/(SICI)1097-0215(20000215)85:4<523::AID-IJC13>3.0.CO;2-6 · DOI
- 10.1002/(SICI)1097-0215(19960621)69:3<218::AID-IJC12>3.0.CO;2-3 · DOI
- 10.1111/j.1440-1827.2006.01925.x · DOI
- 10.1038/bjc.1996.364 · DOI
- 10.1016/S0046-8177(98)80014-2 · DOI
- 10.1002/1097-0142(20000815)89:4<733::AID-CNCR3>3.0.CO;2-# · DOI
- 10.1056/NEJMra040958 · DOI
- Tachikawa D, 2000, Do the expression of CD44, apoptosis and thymidylate synthase inhibition rate correlate with the efficacy of chemotherapy in colorectal cancer?, Anticancer Res, 20, 595
Cited by
Sorted by citations
Piotrowska, U., Szatko, J., Nowakowska, A., Klimaszewska, E., Ogorzałek, M., & Sobczak, M. (2025) · Marine Drugs · doi:10.3390/md23120467 · Cited by 14
Metadata
- Authors
- Huh, J. W., Kim, H. R., Kim, Y. J., Lee, J. H., Park, Y. S., Cho, S. H., & Joo, J. K.
- Venue
- Pathology International
- Publisher
- Wiley
- Published
- 2009-03-30
- Volume
- 59
- Issue
- 4
- Pages
- 241-246
- ISSN
- 1320-5463
- 1440-1827
- Cited by
- 65
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review